{"id":"W2161621338","doi":"10.1016/j.cmet.2013.05.002","title":"RETRACTED: The Cancer-Associated FGFR4-G388R Polymorphism Enhances Pancreatic Insulin Secretion and Modifies the Risk of Diabetes","year":2013,"lang":"en","type":"article","venue":"Cell Metabolism","topic":"Fibroblast Growth Factor Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":true,"has_abstract":false,"ca_institutions":"University Health Network; Ontario Institute for Cancer Research","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Canadian Institutes of Health Research; Kuopion Yliopistollinen Sairaala; Ontario Ministry of Health and Long-Term Care; Academy of Finland; Diabetestutkimussäätiö; Deutsche Forschungsgemeinschaft; Raymond and Beverly Sackler Foundation; Pfizer","keywords":"Pancreatic cancer; Fibroblast growth factor receptor 4; Biology; Hyperinsulinemia; Allele; Endocrinology; Pancreatic islets; Cancer research; Internal medicine; Insulin; Islet; Type 2 diabetes; Single-nucleotide polymorphism; Fibroblast growth factor; Diabetes mellitus; Cancer; Medicine; Genotype; Receptor; Genetics; Fibroblast growth factor receptor; Gene; Insulin resistance","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":{"nature":"Retraction","reason":"Investigation by Journal/Publisher;Manipulation of Images;Objections by Third Party;Original Data and/or Images not Provided and/or not Available;","date":"10/6/2020 0:00","openalex_flagged":true},"screen":null}